Maala, Maximo T.
HRN: 23-64-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
CEFTRIAXONE 1G (VIAL)
08/31/2023
09/07/2023
IVTT
2g
Q12
TC Brain Abscess Vs Bacterial Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes